Eva Pisa
Fortuna: 217 784 $ al 31/05/2026
Fortuna: 217 784 $ al 31/05/2026
Eva Pisa is currently a Member of the Supervisory Board at QIAGEN NV since 2022.
Formerly, Dr. Pisa was Chief Executive Officer at Cepheid AB from 2001 to 2007 and SVP-Roche Centralized & POC Solutions at Roche Diagnostics International AG from 2007 to 2020.
Education includes a doctorate from Karolinska Institutet and an MBA from Heriot-Watt University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
QIAGEN NV 0 % | 28/02/2026 | 5.952 ( 0 % ) | 217 784 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| QIAGEN N.V. | Director/Miembro de la Junta | 23/06/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
Roche Diagnostics International AG
Roche Diagnostics International AG Medical SpecialtiesHealth Technology Manufactures and supplies diagnostics systems | Corporate Officer/Principal | 01/01/2020 |
Cepheid AB
Cepheid AB Medical/Nursing ServicesHealth Services Develops and provides molecular diagnostic testing | Director Ejecutivo | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
QIAGEN NV
QIAGEN NV Medical SpecialtiesHealth Technology Manufactures and distributes sample and assay technology products for pre-analytical sample preparations | Health Technology |
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Heriot-Watt University
Heriot-Watt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cepheid AB
Cepheid AB Medical/Nursing ServicesHealth Services Develops and provides molecular diagnostic testing | Health Services |
Roche Diagnostics International AG
Roche Diagnostics International AG Medical SpecialtiesHealth Technology Manufactures and supplies diagnostics systems | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.